Mcf Advisors LLC Eli Lilly & CO Transaction History

Mcf Advisors LLC

$1.42 Billion
Q3 2024

A detailed history of Mcf Advisors LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Mcf Advisors LLC holds 2,850 shares of LLY stock, worth $2.15 Million. This represents 0.18% of its overall portfolio holdings.

Number of Shares

2,850

Previous 2,848 0.07%

Holding current value

$2.15 Million

Previous $2.58 Million 2.09%

% of portfolio

0.18%

Previous 0.2%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 24, 2024	BUY	$772.14 - $960.02 $1,544 - $1,920	2 Added 0.07%	2,850 $2.52 Million
Q2 2024 Aug 05, 2024	SELL	$724.87 - $909.04 $5,074 - $6,363	-7 Reduced 0.25%	2,848 $2.58 Million
Q1 2024 Apr 16, 2024	BUY	$592.2 - $792.28 $85,869 - $114,880	145 Added 5.35%	2,855 $2.22 Million
Q4 2023 Feb 01, 2024	BUY	$525.19 - $619.13 $19,957 - $23,526	38 Added 1.42%	2,710 $1.58 Million
Q3 2023 Oct 19, 2023	SELL	$434.7 - $599.3 $79,115 - $109,072	-182 Reduced 6.38%	2,672 $1.44 Million
Q2 2023 Jul 24, 2023	BUY	$350.74 - $468.98 $136,437 - $182,433	389 Added 15.78%	2,854 $1.34 Million
Q1 2023 Apr 18, 2023	BUY	$310.63 - $364.82 $12,425 - $14,592	40 Added 1.65%	2,465 $846,000
Q2 2022 Aug 11, 2022	BUY	$278.73 - $327.27 $53,237 - $62,508	191 Added 8.55%	2,425 $786,000
Q1 2022 May 05, 2022	BUY	$234.69 - $291.66 $524,297 - $651,568	2,234 New	2,234 $639,000
Q4 2021 Feb 14, 2022	SELL	$224.85 - $279.04 $502,314 - $623,375	-2,234 Closed	0 $0
Q3 2021 Nov 12, 2021	BUY	$221.6 - $272.71 $10,193 - $12,544	46 Added 2.1%	2,234 $516,000
Q2 2020 Aug 11, 2020	SELL	$136.42 - $164.18 $167,933 - $202,105	-1,231 Reduced 36.0%	2,188 $359,000
Q3 2019 Oct 22, 2019	BUY	$106.79 - $116.16 $13,562 - $14,752	127 Added 3.86%	3,419 $382,000
Q1 2019 May 07, 2019	SELL	$111.31 - $131.02 $52,872 - $62,234	-475 Reduced 12.61%	3,292 $427,000
Q4 2018 Jan 25, 2019	BUY	$105.9 - $118.64 $211 - $237	2 Added 0.05%	3,767 $436,000
Q3 2018 Oct 24, 2018	BUY	$85.86 - $107.31 $257 - $321	3 Added 0.08%	3,765 $404,000
Q2 2018 Jul 20, 2018	BUY	$75.7 - $86.88 $227 - $260	3 Added 0.08%	3,762 $321,000
Q1 2018 May 10, 2018	BUY	$74.21 - $87.6 $890 - $1,051	12 Added 0.32%	3,759 $291,000
Q4 2017 Feb 06, 2018	BUY	$81.94 - $87.89 $1,147 - $1,230	14 Added 0.38%	3,747 $316,000
Q3 2017 Oct 30, 2017	BUY	$77.07 - $85.54 $287,702 - $319,320	3,733	3,733 $319,000

Others Institutions Holding LLY

# of Institutions

4,004

Shares Held

752M

Call Options Held

8.27M

Put Options Held

10.5M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $717B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Mcf Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Mcf Advisors LLC with notifications on news.

Account